1243 results
News
2023 Annual results
Annual sales: €529 million (stable at constant exchange rates) Essentials sales: €313m (+4.5% at constant exchange rates) Net income - Group share: €56m (10.5% of sales) EBITDA: €113m (21.3% of sales) Free Cash flow: €89 m Matthieu Frechin, Chairman and CEO of Vetoquinol, commented: “In 2023...
Publication
ANNUAL RESULTS 2023 (slideshow)
01.2023 Highlights 02.2023 Consolidated financial statements 03.Strategy and outlook
Publication
2023 ANNUAL RESULTS
Annual sales: €529m (stable at constant exchange rates) Essentials sales: €313m (+4.5% at constant exchange rates) Net income - Group share: €56m (10.5% of sales) EBITDA: €113m (21.3% of sales) Free cash-flow: €89m
Publication
Monthly information regarding the total number of voting rights – February 2024
As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication
Monthly information regarding the total number of voting rights – January 2024
As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication
Annual sales 2023: €529 million
Annual Sales of Essential products: €313 million (up 4.5% at constant exchange rates)
Publication
Monthly information regarding the total number of voting rights – December 2023
As per articles L233‐8‐II of « Code de Commerce » and 223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »
Publication
2024 Calendar of financial communication
Vetoquinol published its calendar of financial communication for 2024.